Yield10 Bioscience Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $2.5
- Today's High:
- $2.625
- Open Price:
- $2.61
- 52W Low:
- $1.63
- 52W High:
- $6.12
- Prev. Close:
- $2.66
- Volume:
- 9641
Company Statistics
- Market Cap.:
- $12.69 million
- Book Value:
- 0.89
- Revenue TTM:
- $450000
- Operating Margin TTM:
- -2989.11%
- Gross Profit TTM:
- $-7300000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -59%
- Return on Equity TTM:
- -132.83%
Company Profile
Yield10 Bioscience Inc had its IPO on 2006-11-10 under the ticker symbol YTEN.
The company operates in the Basic Materials sector and Agricultural Inputs industry. Yield10 Bioscience Inc has a staff strength of 30 employees.
Stock update
Shares of Yield10 Bioscience Inc opened at $2.61 at the start of the last trading session i.e. 2023-03-24.
The stocks traded within a range of $2.5 - $2.63, and closed at $2.5.
This is a -6.02% slip from the previous day's closing price.
A total volume of 9,641 shares were traded at the close of the day’s session.
In the last one week, shares of Yield10 Bioscience Inc have slipped by -3.1%.
Yield10 Bioscience Inc's Key Ratios
Yield10 Bioscience Inc has a market cap of $12.69 million, indicating a price to book ratio of 1.2806 and a price to sales ratio of 16.8007.
In the last 12-months Yield10 Bioscience Inc’s revenue was $450000 with a gross profit of $-7300000 and an EBITDA of $-13188000. The EBITDA ratio measures Yield10 Bioscience Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Yield10 Bioscience Inc’s operating margin was -2989.11% while its return on assets stood at -59% with a return of equity of -132.83%.
In Q4, Yield10 Bioscience Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 42.8%.
Yield10 Bioscience Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-2.75 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Yield10 Bioscience Inc’s profitability.
Yield10 Bioscience Inc stock is trading at a EV to sales ratio of 9.1003 and a EV to EBITDA ratio of -0.3615. Its price to sales ratio in the trailing 12-months stood at 16.8007.
Yield10 Bioscience Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $8.09 million
- Total Liabilities
- $1.61 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Yield10 Bioscience Inc ended 2023 with $8.09 million in total assets and $0 in total liabilities. Its intangible assets were valued at $8.09 million while shareholder equity stood at $4.40 million.
Yield10 Bioscience Inc ended 2023 with $0 in deferred long-term liabilities, $1.61 million in other current liabilities, 49000.00 in common stock, $-399697000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $2.36 million and cash and short-term investments were $4.35 million. The company’s total short-term debt was $575,000 while long-term debt stood at $0.
Yield10 Bioscience Inc’s total current assets stands at $5.02 million while long-term investments were $0 and short-term investments were $1.99 million. Its net receivables were $0 compared to accounts payable of $109000.00 and inventory worth $0.
In 2023, Yield10 Bioscience Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Yield10 Bioscience Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $2.5
- 52-Week High
- $6.12
- 52-Week Low
- $1.63
- Analyst Target Price
- $14.67
Yield10 Bioscience Inc stock is currently trading at $2.5 per share. It touched a 52-week high of $6.12 and a 52-week low of $6.12. Analysts tracking the stock have a 12-month average target price of $14.67.
Its 50-day moving average was $3.21 and 200-day moving average was $2.73 The short ratio stood at 4.37 indicating a short percent outstanding of 0%.
Around 1832.4% of the company’s stock are held by insiders while 949% are held by institutions.
Frequently Asked Questions About Yield10 Bioscience Inc
Similar Industry Stocks (Agricultural Inputs)
Most Active
Top Gainers
Top Losers
About
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.